Patent application number | Description | Published |
20150146408 | Phosphor, Method for Producing Same, Light Emitting Device, and Image Display Device - To provide a phosphor being chemically-thermally stable and having high luminous intensity if combined with LED of not exceeding 470 nm. A phosphor of the present invention includes: inorganic compound including: a crystal represented by Li | 05-28-2015 |
20150175881 | Fluorophore, Method for Producing Same, Light-Emitting Device, and Image Display Device - Provided is chemically and thermally stable phosphor having light-emitting characteristics different from the conventional phosphor and high emission intensity when combined with LED of not exceeding 470 nm. The phosphor comprises inorganic compound having crystal represented by A | 06-25-2015 |
20150179899 | Fluorophore, Method for Producing Same, Light-Emitting Device Using Fluorophore, Image Display Device, Pigment, and Ultraviolet Absorbent - Provided is fluorophore comprising: inorganic compound having: an inorganic crystal, where M element (M is one or more elements selected from Mn, Ce, Pr, Nd, Sm, Eu, Tb, Dy, and Yb) is solid solved, having the same crystal structure as the crystal represented by Ca | 06-25-2015 |
20160060518 | PHOSPHOR, METHOD FOR PRODUCING SAME, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS - Provided is a chemically and thermally stable phosphor having different light-emitting characteristics than a conventional phosphor and having high light-emitting intensity even when combined with an LED of 410 nm or lower. The phosphor comprises an inorganic compound in which an inorganic crystal including A element, D element, X element (A is one or more elements selected from Mg, Ca, Sr, and Ba; D is one or more elements selected from Si, Ge, Sn, Ti, Zr, and Hf; and X is one or more elements selected from O, N, and F), and, if necessary, E element (where E is one or more elements selected from B, Al, Ga, In, Sc, Y, and La) includes Li element and M element (where M is one or more elements selected from Mn, Ce, Pr, Nd, Sm, Eu, Tb, Dy, and Yb). | 03-03-2016 |
20160096991 | PHOSPHOR, PRODUCTION METHOD FOR SAME, LIGHT-EMITTING DEVICE, IMAGE DISPLAY DEVICE, PIGMENT, AND ULTRAVIOLET ABSORBER - A phosphor having different light emission characteristics from the conventional phosphor, having high emission intensity and chemical and thermal stability, combined with LED of less than 450 nm. This phosphor includes an inorganic compound comprising: a crystal represented by Ba | 04-07-2016 |
Patent application number | Description | Published |
20090057549 | Method of Excising Sugar Chain from Glycoprotein, Method of Mass Spectrometry of Sugar Chain, and Method of Mass Spectrometry of Glycoprotein - The present invention provides a method of enzymatic reaction on a membrane by a sugar chain releasing enzyme, for an MALDI-TOF MS analysis of a glycoprotein that is solid-phased on a membrane is conducted directly on the membrane; a method of mass spectrometry of a sugar chain in which a sugar chain, for the MALDI-TOF MS analysis of a sugar chain excised from a glycoprotein that is solid-phased on a membrane is conducted directly on the membrane; and a method of mass spectrometry of a glycoprotein, for the MALDI-TOF MS analysis of a glycoprotein of a glycoprotein that is solid-phased on a membrane is conducted directly on the membrane. A method of excising a sugar chain to obtain excised sugar chains by excising the sugar chains by dispensing a sugar chain releasing enzyme solution on a glycoprotein that is solid-phased on a carrier, wherein the sugar chain releasing enzyme solution is a solution containing a sugar chain releasing enzyme in a reaction buffer solution containing a buffering agent consisting essentially of a volatile component. A method of mass spectrometry of a sugar chain and a method of mass spectrometry of a glycoprotein using the method of excising the sugar chain. | 03-05-2009 |
20090197273 | NOVEL N-ACETYLGALACTOSAMINE TRANSFERASES AND NUCLEIC ACIDS ENCODING THE SAME - An enzyme which transfers N-acetylgalactosamine to N-acetylglucosamine via a β1-4 linkage was isolated and the structure of its gene was explained. This led to the production of said enzyme or the like by genetic engineering techniques, the production of oligosaccharides using said enzyme, and the diagnosis of diseases on the basis of said gene or the like. | 08-06-2009 |
20090216705 | METHOD FOR PREDICTING SUGAR CHAIN STRUCTURE - An object of the present invention is to provide a method for conveniently analyzing sugar chain (isomer) structure using a sample of approximately 1 picomole, which is generally subjected to analysis in proteomics without using any sugar chain preparation. The present invention relates to a method for analyzing sugar chain structure, comprising a step of obtaining the fragmentation pattern of a test sugar chain through fragmentation of the test sugar chain and a step of predicting the structure of the test sugar chain through comparison of the sugar chain predicted fragmentation pattern data generated based on fragmentation pattern templates with the fragmentation pattern of the test sugar chain. | 08-27-2009 |
20110059466 | SUPPORT FOR ELECTROPHORESIS INCLUDING HYDROPHOBIC POLYMER MEMBRANE, AND ELECTROPHORETIC SEPARATION METHOD USING THE SAME - There is provided a membrane electrophoresis which renders possible glycan analysis of polysaccharide and glycoprotein by separating protein, glycoprotein or polysaccharide by electrophoresis, followed by carrying out a glycan-releasing treatment of the membrane used in the electrophoresis, or a membrane electrophoresis which renders possible detection of the same by an immunostaining which uses an antibody, wherein a layer containing a hydrophilic polymer is formed on a hydrophobic polymer membrane by coating the hydrophilic polymer on the whole surface of the hydrophobic polymer membrane or by soaking the hydrophobic polymer membrane in a solution of the hydrophilic polymer, which is used as a substrate for electrophoresis. | 03-10-2011 |
20120065089 | Method For Detecting And Distinguishing Intrahepatic Cholangiocarcinoma - Disclosed are a method for early, sensitively and reliably detecting and distinguishing intrahepatic cholangiocarcinoma in a malignant tumor occurring primarily in the liver in a simple way, and a kit therefor. In the method, a glycan biomarker consisting of a lectin WFA (Wisteria floribunda Agglutinin)-binding glycoprotein derived from intrahepatic cholangiocarcinoma is used as a cancer marker to detect intrahepatic cholangiocarcinoma by detecting the cancer marker in a test specimen. The method for detecting intrahepatic cholangiocarcinoma can clearly differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma and enables early detection and determination with a performance clinically acceptable in terms of applicability, sensitivity and precision. | 03-15-2012 |
20120172247 | Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease - An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Disclosed is a method for measuring at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject, comprising: measuring AGP binding to a first lectin selected from AOL and MAL, when the glycoprotein is AGP; and measuring M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII, when the glycoprotein is M2BP. | 07-05-2012 |
20120190576 | Glycan Markers as Measure of Disease State of Hepatic Diseases - The present invention is directed to developing a glycan markers capable of detecting a hepatic disease, and more specifically to developing a glycan marker indicating a hepatic disease-state. Furthermore, the present invention is also directed to developing a glycan marker capable of distinguishing hepatic disease-states with the progress of hepatocarcinoma. The present inventors identified, among the serum glycoproteins, glycopeptides and glycoproteins in which a glycan structure specifically changes due to a hepatic diseases including hepatocarcinoma and provide these as novel glycan markers (glycopeptide and glycoprotein) specific to hepatic disease-states. | 07-26-2012 |
20130288272 | LUNG CANCER DIFFERENTIAL MARKER - An object of the present invention is to develop and provide a lung cancer differential marker with which lung cancer can be diagnosed conveniently and highly sensitively without depending only on increase or decrease in protein expression level between cancer patients and healthy persons. Another object of the present invention is to develop and provide a glycan marker capable of distinguishing histological types of lung cancer. Of serum glycoproteins, glycopeptide and glycoprotein groups whose glycan structures were altered specifically in lung cancer cell culture supernatants were identified, and they are provided as lung cancer differential markers. | 10-31-2013 |
20140057286 | Method for Measuring Glycoprotein, Method for Examining Liver Desease, Reagent for Quantitative Determination of Glycoprotein and Glycan-Marker Glycoprotein as an Index for Clinical Conditions of Liver Disease - An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a reagent for quantitative determination of a glycoprotein, which is used for the above measurement methods. Furthermore, an object of the present invention is to provide a glycan-marker glycoprotein as an index for clinical conditions of liver disease, which is capable of identifying the clinical conditions of liver disease depending on the progress of liver disease. The method for measuring a glycoprotein is characterized in that: the glycoprotein is at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject; when the glycoprotein is AGP, AGP binding to a first lectin selected from AOL and MAL is measured; and when the glycoprotein is M2BP, M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII is measured. | 02-27-2014 |
20140066617 | METHOD FOR PRODUCING SIALIC-ACID-CONTAINING SUGAR CHAIN - [Problem to be Solved] | 03-06-2014 |
20140242607 | ANTIBODY FOR DETECTING EPITHELIAL OVARIAN CANCER MARKER AND METHOD FOR DIAGNOSING EPITHELIAL OVARIAN CANCER - It is intended to find a highly specific epithelial ovarian cancer marker and to provide an antibody capable of specifically recognizing and detecting the marker or a fragment of the antibody. The present invention provides an anti-β1,6-N-acetylglucosaminyltransferase 5B antibody for diagnosis of epithelial ovarian cancer, i.e., an antibody for detection of a glycosyltransferase β1,6-N-acetylglucosaminyltransferase 5B as an epithelial ovarian cancer marker. The antibody recognizes, as an epitope, a part of a polypeptide of the enzyme consisting of the amino acid sequence represented by SEQ ID NO: 1. | 08-28-2014 |
20140295455 | ANTIBODY FOR DETECTING EPITHELIAL OVARIAN CANCER MARKER AND METHOD FOR DIAGNOSING EPITHELIAL OVARIAN CANCER - The present invention provides an antibody capable of specifically recognizing and detecting the highly specific cancer marker with respect to the epithelial ovarian cancer, or a fragment of the antibody. The present invention provides an anti-β1,3-N-acetylglucosaminyltransferase 3 antibody for diagnosis of epithelial ovarian cancer, i.e., an antibody for detection of a glycosyltransferase β1,3-N-acetylglucosaminyltransferase 3 as an epithelial ovarian cancer marker. The antibody recognizes, as an epitope, a part of a polypeptide of the enzyme consisting of the amino acid sequence represented by SEQ ID NO: 1. | 10-02-2014 |
20140315246 | COMPOSITE SUGAR CHAIN HYDROLASE - The present invention provides a novel endo-β-N-acetylglucosaminidase (Endo-Om) using a transformant produced by cloning an endo-β-N-acetylglucosaminidase (Endo-Om) gene originated from a methylotrophic yeast | 10-23-2014 |
20150293104 | EPITHELIAL OVARIAN CANCER DIFFERENTIATION MARKER - An object of the present invention is to develop and provide an epithelial ovarian cancer diagnosis marker with which epithelial ovarian cancer can be detected inexpensively, conveniently, and low invasively with high accuracy, and a method for determining the presence or absence of epithelial ovarian cancer using the marker. The present invention provides a glycoprotein having a glycan-linked asparagine residue at a particular site of the glycoprotein secreted from an epithelial ovarian cancer cell, or a fragment thereof having the glycan as an epithelial ovarian cancer diagnosis marker. The present invention also provides a method for determining the presence or absence of epithelial ovarian cancer using the glycoprotein. | 10-15-2015 |
Patent application number | Description | Published |
20080299615 | Beta1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same - The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them. | 12-04-2008 |
20090081668 | Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid - A tumor marker nucleic acid of the present invention is concerned with a nucleic acid hybridizing under stringent conditions to a nucleotide sequence described in SEQ ID NO: 1 or a complementary nucleotide sequence thereof. A method of testing canceration of the present invention is a method comprising diagnosing a biological sample as being cancerous when the transcription level of the nucleic acid in the biological sample significantly exceeds that in a normal biological sample as a control. The present invention also relates to a β1,3-N-acetyl-D-glucosaminyltransferase protein having an activity of transferring N-acetyl-D-glucosamine from a donor substrate to an acceptor substrate through β1,3-linkage. | 03-26-2009 |
20100279355 | BETA 1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD OF EXAMINING CANCERATION USING THE SAME - The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them. | 11-04-2010 |
20130004995 | BETA 1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD OF EXAMINING CANCERATION USING THE SAME - The N-acetyl-D-galactosamine transferase protein of the present invention is characterized by transferring N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with β1,3 linkage, and it preferably has the amino acid sequence shown in SEQ ID NO: 2 or 4. The canceration assay according to the present invention uses a nucleic acid for measurement which hybridizes under stringent conditions to the nucleotide sequence shown in SEQ ID NO: 1 or 3 or a nucleotide sequence complementary to at least one of them. | 01-03-2013 |
20150329602 | MODIFIED LECTIN DERIVED FROM WISTERIA FLORIBUNDA - [Problem] The purpose of the present invention is to stably supply high-quality and highly uniform | 11-19-2015 |
Patent application number | Description | Published |
20110043762 | Projector - A projector includes: a first solid-state light source device which includes a first solid-state light source emitting main excitation light, and a fluorescent layer converting main excitation light to light including a first color light component and a second color light component different from the first color light component, and emitting converted light; a second solid-state light source device which includes a second solid-state light source emitting a third color light component different from the first color light component and the second color light component; a light modulation device modulating the first color light component, the second color light component, and the third color light component in accordance with image information; a projection optical system projecting the modulated light components from the light modulation device as a projection image; and a third solid-state light source device which includes a third solid-state light source emitting auxiliary excitation light, wherein the fluorescent layer is configured such that auxiliary excitation light is input thereto in a direction different from a direction in which main excitation light is input, and the fluorescent layer is configured to convert auxiliary excitation light to light including the first color light component and the second color light component, and to emit converted light. | 02-24-2011 |
20110051095 | PROJECTOR - A projector includes: a first solid-state light source device which includes a first solid-state light source emitting main excitation light, and a fluorescent layer converting main excitation light emitted from the first solid-state light source to light including a first color light component and a second color light component different from the first color light component, and emitting converted light; a second solid-state light source device which includes a second solid-state light source emitting a third color light component different from the first color light component and the second color light component; a light modulation device modulating the first color light component, the second color light component, and the third color light component in accordance with image information; a projection optical system projecting the modulated light components from the light modulation device as a projection image; and a color light combining optical system combining light emitted from the first solid-state light source device and the third color light component emitted from the second solid-state light source device. | 03-03-2011 |
20120242714 | DISPLAY DEVICE AND PROJECTOR - Since green is expressed by the first sub-pixels and the second sub-pixels, and at the same time, red is expressed by the third sub-pixels using the yellow illumination light, and green is expressed by the first sub-pixels and the second sub-pixels, and at the same time, blue is expressed by the third sub-pixels using the cyan illumination light, the display device can assure the apparent resolution and the brightness using the first and second sub-pixels with greenish color. It should be noted that red and blue can be expressed by the third sub-pixels with magenta color. | 09-27-2012 |
20140022514 | PROJECTOR AND METHOD FOR CONTROLLING PROJECTOR - A projector including a first light source, a second light source that emits light having a color different from the first light source, a light modulator that modulates the light emitted from each of the first and the second light sources, and a controller that controls a first operation state in which the first and the second light sources are driven based on time division driving to perform image display and a second operation state in which the first and the second light sources are driven based on time division driving to perform illumination, wherein in the second operation state, a switching frequency at which the first and the second light sources are switched from one to the other is higher than a switching frequency at which the first and the second light sources are switched from one to the other in the first operation state. | 01-23-2014 |
20140022515 | PROJECTOR - A projector includes a light source; a spatial light modulation device which modulates light from the light source according to an image that is written; a light diffusion device which adjusts a degree of diffusion of the light incident on the spatial light modulation device or the light emitted from the spatial light modulation device; and a light diffusion controller which controls the light diffusion device so that the light diffusion device diffuses the light when the light source starts to light up. | 01-23-2014 |
20140036164 | PROJECTOR - Two light modulators, a first light modulator and a second light modulator, suffice for four light sources, a first light source, a second light source, a third light source, and a fourth light source, whereby the cost can be lowered as compared with a configuration in which three light modulators are required. As a result, cost reduction is achieved. Further, since two light modulators suffice, the size of the projector can be reduced as compared with the configuration in which three light modulators are required. | 02-06-2014 |
20140139811 | PROJECTOR AND METHOD FOR CONTROLLING THE SAME - A projector includes a power receiving terminal, a light source that emits light based on electric power supplied to the power receiving terminal, a light diffuser that adjusts the degree of diffusion of the light from the light source, a specifying section that alternately specifies one of illumination projection and image projection every time electric power supply to the power receiving terminal is started, and a light diffusion controller that controls the light diffuser so that when the specifying section specifies the illumination projection, the light diffuser diffuses the light from the light source, whereas when the specifying section specifies the image projection, the light diffuser transmits the light without substantially diffusing the light. | 05-22-2014 |
20150022788 | PROJECTOR AND METHOD OF CONTROLLING PROJECTOR - A projector includes a projection section adapted to project light, a human detection section adapted to detect a human existing in a predetermined region, and a mode switching section adapted to switch an operation mode to one of a content mode for projecting light of an image related to a content by the projection section, and an illumination mode for projecting light for illumination by the projection section in accordance with a detection result of the human detection section. | 01-22-2015 |
20150029406 | PROJECTOR AND METHOD FOR CONTROLLING PROJECTOR - A projector includes an electricity reception terminal to which electric power is supplied via an electricity feed terminal, a projection section that includes a light source, a spatial light modulator, an irradiation system, and a projection system and projects light, and a control section that switches a content to another whenever electric power supply to the electricity reception terminal is initiated and causes the projection section to project light carrying an image related to the content selected in the switching operation. | 01-29-2015 |